Gilead

Gilead, Salix, Peregrine, Navidea Approach Key Dates In September
Minyanville
Tue, 09/4/12 - 12:27 pm
Gilead
Salix
Peregrine Pharmaceuticals
Navidea Biopharmaceuticals
Crofelemer
tobramycin
Lymphoseek
bavituximab
Truvada
Eylea
Regeneron
lixivaptan
Cornerstone Therapeutics
Stribild: It's FDA-Approved, but Will It Sell?
Motley Fool
Wed, 08/29/12 - 08:29 am
FDA
HIV
Gilead
Stribild
Gilead pricing for Stribild makes sense, says Deutsche Bank
The Fly on the Wall
Tue, 08/28/12 - 11:02 am
HIV
Gilead
Stribild
pricing
Gilead’s 4-In-1 Stribild HIV Pill Wins U.S. FDA Approval
Bloomberg
Tue, 08/28/12 - 10:56 am
Gilead
FDA
HIV
Quad
Stribild
PropThink: Previewing Gilead's 'Quad' Ahead of FDA Decision
Yahoo/Reuters
Fri, 08/24/12 - 10:59 am
FDA
Quad
HIV
Gilead
Gilead Sciences Will Continue To Grow
Seeking Alpha
Thu, 08/23/12 - 10:04 am
Gilead
Democrats Caution Gilead Over Quad Pricing
Pharmalot
Wed, 08/15/12 - 11:09 am
drug pricing
Gilead
HIV
Quad
Gilead inks low-cost HIV drug deal with generics makers
Fierce Pharma
Thu, 08/2/12 - 01:16 pm
generics
HIV
Gilead
Mylan
Ranbaxy
Strides Arcolab
Vertex's Cystic Fibrosis Pipeline Offers Sales Upside
Seeking Alpha
Thu, 08/2/12 - 10:22 am
cystic fibrosis
Vertex Pharma
AstraZeneca
Gilead
Kalydeco
Pfizer
Rigel Pharmaceuticals
VX-809
6 Healthcare Stocks With Pending August Catalysts
Seeking Alpha
Wed, 08/1/12 - 10:08 am
Abbott Labs
Amgen
Amarin
Arena Pharmaceuticals
Gilead
JNJ
Pfizer
Horizon Pharma
Vivus
Regeneron
Sanofi
Talon Therapeutics
Gilead, Regeneron, Sanofi, Pfizer, Abbott Face Big Dates in August
Minyanville
Tue, 07/31/12 - 01:27 pm
Gilead
Regeneron
Sanofi
Pfizer
Abbott Labs
Roche Building On Its Strengths
Seeking Alpha
Mon, 07/30/12 - 11:44 am
Roche
Abbott Labs
AstraZeneca
Gilead
Complete Genomics
Sanofi
Pfizer
Pacific Biosciences
JNJ
Novartis
Illumina
GSK
Gilead Sciences Firing On All Cylinders
TheStreet.com
Mon, 07/30/12 - 10:26 am
Gilead
GSK
Bristol-Myers Squibb
Pay Attention to These Biotechs
Yahoo/TheStreet.com
Fri, 07/27/12 - 12:50 pm
Gilead
Amgen
Celgene
Gilead Begins Single Pill Hepatitis C Study For 2014 Approval
Bloomberg
Fri, 07/27/12 - 12:02 pm
GS-7977
hepatitis C
Gilead
Amgen, Gilead Pop After Quarterly Earnings Beats
Investors.com
Fri, 07/27/12 - 11:41 am
earnings
Amgen
Gilead
GlaxoSmithKline's R&D Is Delivering, But The Street's Not Buying
Seeking Alpha
Wed, 07/25/12 - 11:32 pm
R&D
GSK
Pfizer
Theravance
Human Genome Sciences
Gilead
Gilead HIV drug as good as Merck's Isentress: study
Reuters
Wed, 07/25/12 - 09:30 am
Gilead
HIV
Merck
Isentress
elvitegravir
Quad
Investing in the Companies that will Beat HIV
Motley Fool
Wed, 07/25/12 - 09:22 am
HIV
Gilead
JNJ
Merck
Bristol-Myers Squibb
28 Drugs Facing FDA Approval in 2012-2013
TheStreet.com
Tue, 07/24/12 - 09:52 am
FDA
Amarin
Horizon Pharma
Salix
Progenics Pharmaceuticals
Regeneron
Sanofi
Talon Therapeutics
Gilead
Pfizer
Ironwood
Celgene
NPS Pharmaceuticals
Navidea Biopharmaceuticals

Pages